Algenates
Alginate drug delivery utilizes the exceptional properties of seaweed to achieve exceptional results in various pharmaceutical and nutraceutical applications. Seaweed-derived alginates exhibit notable characteristics, including their ability to increase the viscosity of solutions and form a three-dimensional gel when exposed to calcium ions. These distinctive functionalities find practical application in a diverse array of fields, such as controlled release dosage forms, enteric coatings, microencapsulation, and stabilization of solutions and suspensions.
Moreover, alginates play an active role in certain anti-reflux products, further showcasing their versatility. When sourced from IFF (International Flavors & Fragrances), alginates prove to be an outstanding choice for ensuring consistent performance across a wide range of applications, from anti-reflux remedies to biomedical implants. Benefiting from decades of experience in managing these naturally derived materials, IFF guarantees reliability and consistent performance, making alginates an invaluable solution for various industries.
PRODUCT RECOMMENDATIONS
Product | Application | Type | Viscosity, cps (1%) | G / M range |
---|---|---|---|---|
Protanal® LFR 5/60* | Anti-reflux | Sodium alginate | 5–7 | 65–75 / 25–35 |
Protacid® F120NM | Anti-reflux | Alginic acid | Insoluble | 65–75 / 25–35 |
Protanal® CR 8133* | Controlled Release | Sodium alginate | 15–45 | 30–40 / 60–70 |
Manucol® LKX | Controlled Release | Sodium alginate | 60–170 | 30–40 / 60–70 |
Protanal® CR 8223* | Controlled Release | Sodium alginate | 200–450 | 30–40 / 60–70 |
Aquateric® N100 | Enteric Coating | Sodium alginate | 4–12 | 30–40 / 60–70 |
* Also recommended as solid-dispersion and nano-suspension solubilizer.